Literature DB >> 6509550

DNAase I encapsulated in liposomes can induce neoplastic transformation of Syrian hamster embryo cells in culture.

M Zajac-Kaye, P O Ts'o.   

Abstract

We have used liposomes to deliver DNAase I inside normal Syrian hamster embryo (SHE) cells. We showed the entrance of DNAase I inside the cell by dose-dependent cytotoxicity; and the entrance of DNAase I into the nucleus by the induction of chromosomal aberrations and somatic mutation at the HPRT locus (but not at the Na+/K+ ATPase locus). The induction of neoplastic transformation in cultures treated by DNAase I-in-liposomes was manifested by increased saturation density, colony formation at low seeding density, colony formation in 1% serum and 0.3% agar, and tumorigenicity in 100% of injected animals. The acquisition of anchorage-independent growth became apparent only after 39-57 posttreatment population doublings. Thus damage to DNA alone can initiate the neoplastic transformation process; but for full expression of the neoplastic phenotypes, a long progression time is required for the acquisition of anchorage-independent growth and tumorigenicity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6509550     DOI: 10.1016/0092-8674(84)90450-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  6 in total

1.  Non random distribution of lesions induced by deoxyribonuclease I in human chromosomes.

Authors:  F Nuzzo; A Casati; E Raimondi
Journal:  Cytotechnology       Date:  1987-10       Impact factor: 2.058

2.  Coinfection with viruses carrying the v-Ha-ras and v-myc oncogenes leads to growth factor independence by an indirect mechanism.

Authors:  M Vogt; J Lesley; J Bogenberger; S Volkman; M Haas
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

3.  DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.

Authors:  W G Nelson; M B Kastan
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

4.  Scientific Opinion on Flavouring Group Evaluation 67, Revision 3 (FGE.67Rev3): consideration of 23 furan-substituted compounds evaluated by JECFA at the 55th, 65th, 69th and 86th meetings.

Authors:  Maged Younes; Gabriele Aquilina; Laurence Castle; Karl-Heinz Engel; Paul Fowler; Maria Jose Frutos Fernandez; Peter Fürst; Ursula Gundert-Remy; Rainer Gürtler; Trine Husøy; Melania Manco; Peter Moldeus; Sabina Passamonti; Romina Shah; Ine Waalkens-Berendsen; Detlef Wölfle; Matthew Wright; Romualdo Benigni; Claudia Bolognesi; Kevin Chipman; Eugenia Cordelli; Gisela Degen; Daniel Marzin; Camilla Svendsen; Maria Carfì; Giorgia Vianello; Wim Mennes
Journal:  EFSA J       Date:  2021-02-03

Review 5.  Recessive mechanisms of malignancy.

Authors:  A R Green
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

6.  A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets.

Authors:  Ruli Gao; Chunxia Cao; Min Zhang; Maria-Cecilia Lopez; Yuanqing Yan; Zirong Chen; Yoshitsugu Mitani; Li Zhang; Maria Zajac-Kaye; Bin Liu; Lizi Wu; Rolf Renne; Henry V Baker; Adel El-Naggar; Frederic J Kaye
Journal:  Oncotarget       Date:  2014-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.